|Dr. Bernard Gilly Ph.D.||Exec. Chairman||11.96k||N/A||1957|
|Mr. Lloyd Diamond||CEO & Director||401.02k||N/A||1968|
|Mr. Guillaume Renondin||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Guillaume Buc||Chief Technology Officer||N/A||N/A||N/A|
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system to treat blindness caused by degeneration of photoreceptor cells in the retina. The company has collaboration agreements with Stanford University in California, Institut de la Vision, Moorfields Eye Hospital, Institute of Ocular Microsurgery, University Hospital, and UPMC. Pixium Vision SA was founded in 2011 and is based in Paris, France.
Pixium Vision SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.